Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced that the Froedtert & the Medical College of Wisconsin health network is now screening patients with IntelliSep® in a pilot at its flagship hospital, Froedtert Hospital in Milwaukee. IntelliSep is the first U.S. Food and Drug Administration (FDA)-cleared rapid diagnostic test for the early detection of seps

Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announces that a long standing healthcare client based in California has expanded its contract subscribing to another K5 Autonomous Security Robot (“ASR”). The client originally deployed their first K5 ASR in 2023 and, based off that success, it was decided that a second robot

Xsolis, the AI-driven health technology company fostering collaboration between healthcare providers and payers, today announced an expansion of its partnership with West Tennessee Healthcare, a healthcare system with seven hospitals serving West Tennessee, to streamline medical necessity case reviews and reduce length of stay. The collaboration between Xsolis and West Tennessee Healthcare has led West Tennessee Healthcare to $5.1 million in savings since the beginning of their engagement.

Lucid Diagnostics Inc. a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the peer-reviewed publication of an analytical validation study of its EsoGuard® Esophageal DNA test for the diagnosis of esophageal precancer (Barrett's Esophagus or BE) and esophageal adenocarcinoma (EAC) on samples collected non-endoscopically using Lucid's EsoCheck® Esophageal Cell Collection Device. The manuscript, ent

Medline, a market-leading manufacturer and supplier of medical supplies and solutions, announced today that it is the first healthcare product supplier to achieve the Diamond-level Healthcare Industry Resilience Collaborative (HIRC) Resiliency Badge for manufacturing. This award serves as a recognition of the company’s relentless commitment to resiliency within the healthcare supply chain. The badge recognizes Medline for its best-in-class global manufacturing and supply chain

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ – today announced that the Centers for Medicare and Medicaid Services (CMS) has announced its plan to retire a draft LCD that would have restricted coverage for non-invasive blood-based surveillance testing for allograft rejection. Combined with the February 2024 removal of restrictive language in the accompanying Billing Article and based on discussions with CMS, CareDx believes that longstanding coverage for AlloSure®, Al

DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is offering its novel BRAIN AGE® Brain Health AI Platform (“BRAIN AGE®”) as a clinical tool for investigating the impact of weight loss drugs, such as Semaglutide, on brain function. In a recently published study, Semaglutide, a GLP-1 receptor agonist that has been approved by the FDA and is currently

Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, announces positive new study results for its CVAC System in kidney stone clearance. The new data show that healthcare consumption (HC) events including emergency department (ED) visits, hospitalization and retreatment were significantly lower after steerable ureteroscopic renal evacuation (SURE) with the CVAC System compared to ureteroscopy (URS). The new 1-year multi-center ASPIRE study re

MolecuLight Corp. , the global leader in fluorescence imaging technology for the real-time detection of harmful bacteria in wound care, proudly reaffirms its commitment to equitable wound care with a recent publication by senior author Charles Andersen , MD , and colleagues, "Bacterial Fluorescence Imaging to Address Racial Inequities in Wound Infection Assessment," published in the journal Advances in Skin & Wound Care. The article highlights systemic inequities in he

XpertDox, a leading AI-powered medical coding software provider, has announced a new partnership with QuickVisit Urgent Care, an urgent care service dedicated to underserved communities. This collaboration aims to streamline medical coding processes and optimize the revenue cycle in QuickVisit's urgent care clinics. Established in 2020, QuickVisit Urgent Care offers accessible and affordable healthcare in rural regions, catering to patients of all ages. Currently operating clini